文献速递冠心病

急性冠脉综合征患者经桡动脉与股动脉入路对比

Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation.
PubMed 文献 · Eur Heart J · 2017-01-01

MATRIX研究按STEMI(桡动脉2001例、股动脉2009例)与NSTE-ACS(桡动脉2196例、股动脉2198例)分层随机,比较桡动脉与股动脉入路。30天MACE在STEMI为6.1%对6.3%(RR=0.96,95%CI=0.75-1.24,P=0.76),在NSTE-ACS为11.3%对13.9%(RR=0.80,95%CI=0.67-0.96,P=0.016);NACE在STEMI为7.2%对8.3%(RR=0.86,95%CI=0.68-1.08,P=0.18),在NSTE-ACS为12.2%对14.7%(RR=0.82,95%CI=0.69-0.97,P=0.023)。结论为桡动脉入路在全谱ACS患者中获益一致。

要点

  • NSTE-ACS患者桡动脉较股动脉降低MACE(RR=0.80,95%CI=0.67-0.96,P=0.016)。
  • STEMI患者桡动脉与股动脉MACE无显著差异(RR=0.96,95%CI=0.75-1.24,P=0.76)。
  • 全因死亡与入路部位可处理出血倾向桡动脉,与ACS类型无关。

核心结论

  • 桡动脉与股动脉入路相比,在全部ACS患者中获益一致,无证据表明就诊综合征类型影响随机入路分配的结果。

研究设计与样本

  • MATRIX项目将患者随机分配至桡动脉或股动脉入路,按STEMI(桡动脉2001例、股动脉2009例)与NSTE-ACS(桡动脉2196例、股动脉2198例)分层。

主要发现

  • STEMI患者30天MACE桡动脉121例(6.1%)对股动脉126例(6.3%)(RR=0.96,95%CI=0.75-1.24,P=0.76)。
  • NSTE-ACS患者30天MACE桡动脉248例(11.3%)对股动脉303例(13.9%)(RR=0.80,95%CI=0.67-0.96,P=0.016)(Pint=0.25)。
  • STEMI患者30天NACE桡动脉142例(7.2%)对股动脉165例(8.3%)(RR=0.86,95%CI=0.68-1.08,P=0.18)。
  • NSTE-ACS患者30天NACE桡动脉268例(12.2%)对股动脉321例(14.7%)(RR=0.82,95%CI=0.69-0.97,P=0.023)(Pint=0.76)。
  • 全因死亡与入路部位可处理出血倾向桡动脉,与ACS类型无关(Pint分别为0.11和0.36)。

关键数值与推荐

  • 30天共同主要结局为MACE(死亡、心肌梗死或卒中)与NACE(MACE或大出血)。
  • 在总体研究人群中,桡动脉入路降低了NACE但未降低MACE终点,预设α为0.025。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To assess whether radial compared with femoral access is associated with consistent outcomes in patients with ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation acute coronary syndrome (NSTE-ACS). METHODS AND RESULTS: In the Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX (MATRIX) programme patients were randomized to radial or femoral access, stratified by STEMI (2001 radial, 2009 femoral) and NSTE-ACS (2196 radial, 2198 femoral). The 30-day co-primary outcomes were major adverse cardiovascular events (MACE), defined as death, myocardial infarction, or stroke, and net adverse clinical events (NACE), defined as MACE or major bleeding In the overall study population, radial access reduced the NACE but not MACE endpoint at the prespecified 0.025 alpha. MACE occurred in 121 (6.1%) STEMI patients with radial access vs. 126 (6.3%) patients with femoral access [rate ratio (RR) = 0.96, 95% CI = 0.75-1.24; P = 0.76] and in 248 (11.3%) NSTE-ACS patients with radial access vs. 303 (13.9%) with femoral access (RR = 0.80, 95% CI = 0.67-0.96; P = 0.016) (Pint = 0.25). NACE occurred in 142 (7.2%) STEMI patients with radial access and in 165 (8.3%) patients with femoral access (RR = 0.86, 95% CI = 0.68-1.08; P = 0.18) and in 268 (12.2%) NSTE-ACS patients with radial access compared with 321 (14.7%) with femoral access (RR = 0.82, 95% CI = 0.69-0.97; P = 0.023) (Pint = 0.76). All-cause mortality and access site-actionable bleeding favoured radial access irrespective of ACS type (Pint = 0.11 and Pint = 0.36, respectively). CONCLUSION: Radial as compared with femoral access provided consistent benefit across the whole spectrum of patients with ACS, without evidence that type of presenting syndrome affected the results of the random access allocation.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Vranckx P, Frigoli E, Rothenbühler M, et al. Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation. Eur Heart J. 2017. PMID: 28329389. doi:10.1093/eurheartj/ehx048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。